A preventive strategy of cardiovascular disease is the identification and treatment of high-risk individuals.1,2 One major challenge with this strategy is that it requires tools to discriminate high-risk individuals from other individuals by appropriate screening tests and stratification methods. Furthermore, once individuals have been categorised by risk, it might seem that everything has been decided: high-risk individuals should be treated whereas others should not. However, there follows another major issue: should patients initially not categorised at high risk be rescreened? And, if yes, in which time interval?
No takes yet. Share an insight, caveat, or question.
Chioléro et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: